Genetic variants associated with increased risk of malignant pleural mesothelioma: a genome-wide association study

Asbestos exposure is the main risk factor for malignant pleural mesothelioma (MPM), a rare aggressive tumor. Nevertheless, only 5-17% of those exposed to asbestos develop MPM, suggesting the involvement of other environmental and genetic risk factors. To identify the genetic risk factors that may co...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 8; no. 4; p. e61253
Main Authors Matullo, Giuseppe, Guarrera, Simonetta, Betti, Marta, Fiorito, Giovanni, Ferrante, Daniela, Voglino, Floriana, Cadby, Gemma, Di Gaetano, Cornelia, Rosa, Fabio, Russo, Alessia, Hirvonen, Ari, Casalone, Elisabetta, Tunesi, Sara, Padoan, Marina, Giordano, Mara, Aspesi, Anna, Casadio, Caterina, Ardissone, Francesco, Ruffini, Enrico, Betta, Pier Giacomo, Libener, Roberta, Guaschino, Roberto, Piccolini, Ezio, Neri, Monica, Musk, Arthur W B, de Klerk, Nicholas H, Hui, Jennie, Beilby, John, James, Alan L, Creaney, Jenette, Robinson, Bruce W, Mukherjee, Sutapa, Palmer, Lyle J, Mirabelli, Dario, Ugolini, Donatella, Bonassi, Stefano, Magnani, Corrado, Dianzani, Irma
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 23.04.2013
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Asbestos exposure is the main risk factor for malignant pleural mesothelioma (MPM), a rare aggressive tumor. Nevertheless, only 5-17% of those exposed to asbestos develop MPM, suggesting the involvement of other environmental and genetic risk factors. To identify the genetic risk factors that may contribute to the development of MPM, we conducted a genome-wide association study (GWAS; 370,000 genotyped SNPs, 5 million imputed SNPs) in Italy, among 407 MPM cases and 389 controls with a complete history of asbestos exposure. A replication study was also undertaken and included 428 MPM cases and 1269 controls from Australia. Although no single marker reached the genome-wide significance threshold, several associations were supported by haplotype-, chromosomal region-, gene- and gene-ontology process-based analyses. Most of these SNPs were located in regions reported to harbor aberrant alterations in mesothelioma (SLC7A14, THRB, CEBP350, ADAMTS2, ETV1, PVT1 and MMP14 genes), causing at most a 2-3-fold increase in MPM risk. The Australian replication study showed significant associations in five of these chromosomal regions (3q26.2, 4q32.1, 7p22.2, 14q11.2, 15q14). Multivariate analysis suggested an independent contribution of 10 genetic variants, with an Area Under the ROC Curve (AUC) of 0.76 when only exposure and covariates were included in the model, and of 0.86 when the genetic component was also included, with a substantial increase of asbestos exposure risk estimation (odds ratio, OR: 45.28, 95% confidence interval, CI: 21.52-95.28). These results showed that genetic risk factors may play an additional role in the development of MPM, and that these should be taken into account to better estimate individual MPM risk in individuals who have been exposed to asbestos.
Bibliography:Competing Interests: The authors declare no competing financial interest. In fact, the “PathWest Laboratory Medicine WA” is not a commercial funder of this research. The authors Jennie Hui and John Beilby are employed by PathWest and do not have any additional consultancy, patents, products in development or marketed products with competing interests relating to this research. Thus, PathWest affiliation does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Contributed to writing the manuscript: SG CDG AR GF FR. Evaluated asbestos exposure: DM. Obtained and/or supervised clinical information: RG EP AH FA ER CC SM. Obtained funding for sample collection and genotyping: ID GM CM LJP ALJ SB DU DM PGB. Participated in critical review of the manuscript for intellectual content: GM SG MB GF DF FV GC CDG FR AR AH EC ST MP MG AA CC FA ER PGB RL RG EP MN AWBM NHdK JH JB ALJ JC BWR SM LJP DM DU SB CM ID. Conceived and designed the experiments: ID GM SB CM. Performed the experiments: SG AR MB AA EC FR ID GM JH. Analyzed the data: GF CM DF ST FV GC CDG FR MP. Contributed reagents/materials/analysis tools: MB MN DU RL MG PGB SB AH JC BWR AWBM LJP ALJ NHdK JB CC FA. Wrote the paper: GM ID CM.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0061253